東北大学

東北大学大学院医学系研究科
腎臓内科学分野
東北大学病院　腎臓・高血圧内科

論文・著書

～歴史ある論文・著書～

2019年

論文【英文】

  1. Sato K, Kumagai N, Suzuki N. Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease Progression. Front Genet. 2019 Nov 13;10:1134. doi: 10.3389/fgene.2019.01134. eCollection 2019.
  2. Nezu M, Kudo M, Ono Y, Tezuka Y, Morimoto R, Sawada S, Imoto H, Naitoh T, Katagiri H, Ito S, Satoh F. Laparoscopic Sleeve Gastrectomy on Severe Obesity after Intracranial Germinoma Treatment: A Case Report. Tohoku J Exp Med. 2019 Nov;249(3):223-229. doi: 10.1620/tjem.249.223.
  3. Itto R, Oe Y, Imaruoka K, Sato E, Sekimoto A, Yamakage S, Kumakura S, Sato H, Ito S, Takahashi N. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist. Tohoku J Exp Med. 2019 Oct;249(2):127-133. doi: 10.1620/tjem.249.127.
  4. Rakugi H, Ito S, Itoh H, Okuda Y, Yamakawa S. Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension. Hypertens Res. 2019 Dec;42(12):1932-1941. doi: 10.1038/s41440-019-0314-7. Epub 2019 Sep 25.
  5. Rahman M, Watabe H, Shidahara M, Watanuki S, Tashiro M, Mori T, Ito S, Ohsaki Y. Renal statistical map for positron emission tomography with [O-15] water. Am J Nucl Med Mol Imaging. 2019 Aug 15;9(4):193-202. eCollection 2019.
  6. Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Asada S, Kawata N, Naruse M. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study. Endocr J. 2019 Dec 25;66(12):1063-1072. doi: 10.1507/endocrj.EJ19-0125. Epub 2019 Sep 10.
  7. Kanehara K, Ohnuma S, Kanazawa Y, Sato K, Kokubo S, Suzuki H, Karasawa H, Suzuki T, Suzuki C, Naitoh T, Unno M, Abe T. The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model. Sci Rep. 2019 Sep 4;9(1):12739. doi: 10.1038/s41598-019-48974-9.
  8. Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J Jr, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Dun Wu K, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina AC. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling. Hypertension. 2019 Oct;74(4):800-808. doi: 10.1161/HYPERTENSIONAHA.119.13463. Epub 2019 Sep 3.
  9. Sato K, Hirano I, Sekine H, Miyauchi K, Nakai T, Kato K, Ito S, Yamamoto M, Suzuki N. An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts. Sci Rep. 2019 Aug 2;9(1):11254. doi: 10.1038/s41598-019-47766-5.
  10. Gao X, Yamazaki Y, Tezuka Y, Onodera Y, Ogata H, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. J Steroid Biochem Mol Biol. 2019 Oct;193:105434. doi: 10.1016/j.jsbmb.2019.105434. Epub 2019 Jul 24.
  11. Nakano M, Kubo K, Shirota Y, Iwasaki Y, Takahashi Y, Igari T, Inaba Y, Takeshima Y, Tateishi S, Yamashita H, Miyazaki M, Sato H, Kanda H, Kaneko H, Ishii T, Fujio K, Tanaka N, Mimori A. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan. Lupus. 2019 Aug;28(9):1062-1073. doi: 10.1177/0961203319860200. Epub 2019 Jul 11.
  12. Ito S, Shikata K, Nangaku M, Okuda Y, Sawanobori T. Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1161-1172. doi: 10.2215/CJN.14751218. Epub 2019 Jun 27.
  13. Sakota M, Tatebe S, Sugimura K, Aoki T, Yamamoto S, Sato H, Kikuchi N, Konno R, Terui Y, Satoh K, Tezuka Y, Morimoto R, Saito M, Kuniyoshi S, Shimokawa H. Successful Management of Acute Congestive Heart Failure by Emergent Caesarean Section Followed by Adrenalectomy in a Pregnant Woman with Cushing's Syndrome-induced Cardiomyopathy. Intern Med. 2019 Oct 1;58(19):2819-2824. doi: 10.2169/internalmedicine.2427-18. Epub 2019 Jun 27.
  14. Itoh H, Ito S, Rakugi H, Okuda Y, Nishioka S. Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study. Hypertens Res. 2019 Oct;42(10):1572-1581. doi: 10.1038/s41440-019-0270-2. Epub 2019 Jun 25.
  15. Asayama K, Ohkubo T, Rakugi H, Miyakawa M, Mori H, Katsuya T, Ikehara Y, Ueda S, Ohya Y, Tsuchihashi T, Kario K, Miura K, Hasebe N, Ito S, Umemura S; Japanese Society of Hypertension Working Group on the COmparison of Self-measured home, Automated unattended office and Conventional attended office blood pressure (COSAC) study. Comparison of blood pressure values-self-measured at home, measured at an unattended office, and measured at a conventional attended office. Hypertens Res. 2019 Nov;42(11):1726-1737. doi: 10.1038/s41440-019-0287-6. Epub 2019 Jun 21.
  16. Ma Z, Ozaki H, Ishikawa Y, Jingu K. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids. Jpn J Radiol. 2019 Aug;37(8):612-618. doi: 10.1007/s11604-019-00846-y. Epub 2019 Jun 14.
  17. Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H. Diabetes Care Providers' Manual for Disaster Diabetes Care. J Diabetes Investig. 2019 Jul;10(4):1118-1142. doi: 10.1111/jdi.13053. Epub 2019 Jun 14.
  18. Ito S, Itoh H, Rakugi H, Okuda Y, Yamakawa S. Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study. J Hum Hypertens. 2019 Jul;33(7):542-551. doi: 10.1038/s41371-019-0207-x. Epub 2019 May 21.
  19. Ishidoya S, Kawasaki Y, Namiki S, Morimoto R, Takase K, Ito A. Changes in quality of life after laparoscopic adrenalectomy for patients with primary aldosteronism: Prospective 2-year longitudinal cohort study in a Japanese tertiary center. Int J Urol. 2019 Jul;26(7):752-753. doi: 10.1111/iju.14016. Epub 2019 May 15.
  20. Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.
  21. Tezuka Y, Yamazaki Y, Kitada M, Morimoto R, Kudo M, Seiji K, Takase K, Kawasaki Y, Mitsuzuka K, Ito A, Nishikawa J, Asai N, Nakamura Y, Gomez-Sanchez CE, Ito S, Dezawa M, Sasano H, Satoh F. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status. Hypertension. 2019 Jun;73(6):1283-1290. doi: 10.1161/HYPERTENSIONAHA.118.12064.
  22. Akaishi T, Kiyomoto H, Abe M, Okuda H, Ishizawa K, Endo T, Miyata M, Nakayama K, Ito S, Tominaga T, Ishii T. A 29-year-old Woman with Recurrent Pregnancy-induced Hypertension Based on Vascular Compression of the Medulla Oblongata. Intern Med. 2019 Aug 1;58(15):2257-2261. doi: 10.2169/internalmedicine.2382-18. Epub 2019 Apr 17.
  23. Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, Bacha JDA, Yamada H, Lauterbach MA, Guillon M, Kaneko K, Norris JW, Siriwardena K, Blasér S, Teillon J, Mendoza-Londono R, Russeau M, Hadoux J, Ito S, Corvol P, Matheus MG, Holden KR, Takei K, Emiliani V, Bennaceur-Griscelli A, Schwartz CE, Nguyen G, Groszer M. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. J Clin Invest. 2019 Apr 15;129(5):2145-2162. doi: 10.1172/JCI79990. eCollection 2019 Apr 15.
  24. Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S. JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration. Hypertens Res. 2019 Oct;42(10):1483-1484. doi: 10.1038/s41440-019-0261-3. Epub 2019 Apr 8.
  25. Higuchi S, Ota H, Ueda T, Tezuka Y, Omata K, Ono Y, Morimoto R, Kudo M, Satoh F, Takase K. 3T MRI evaluation of regional catecholamine-producing tumor-induced myocardial injury. Endocr Connect. 2019 May 1;8(5):454-461. doi: 10.1530/EC-18-0553.
  26. Mishima E, Haruna Y, Arima H. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 2019 Apr;42(4):469-482. doi: 10.1038/s41440-018-0116-3. Epub 2019 Apr 5.
  27. Akaishi T, Abe M, Okuda H, Ishizawa K, Abe T, Ishii T, Ito S. High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells. Sci Rep. 2019 Mar 26;9(1):5214. doi: 10.1038/s41598-019-41536-z.
  28. Oe Y, Fushima T, Sato E, Sekimoto A, Kisu K, Sato H, Sugawara J, Ito S, Takahashi N. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep. 2019 Feb 27;9(1):2986. doi: 10.1038/s41598-019-39914-8.
  29. Elkordy A, Rashad S, Shehabeldeen H, Mishima E, Niizuma K, Abe T, Tominaga T. tiRNAs as a novel biomarker for cell damage assessment in in vitro ischemia-reperfusion model in rat neuronal PC12 cells. Brain Res. 2019 Jul 1;1714:8-17. doi: 10.1016/j.brainres.2019.02.019. Epub 2019 Feb 16.
  30. Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y. Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial. Clin J Am Soc Nephrol. 2019 Mar 7;14(3):354-363. doi: 10.2215/CJN.07720618. Epub 2019 Feb 12.
  31. Imaruoka K, Oe Y, Fushima T, Sato E, Sekimoto A, Sato H, Sugawara J, Ito S, Takahashi N. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide. Biochem Biophys Res Commun. 2019 Mar 19;510(4):587-593. doi: 10.1016/j.bbrc.2019.01.110. Epub 2019 Feb 7.
  32. Kumakura S, Nakamichi T, Suzuki N, Yamakage S, Ishikawa A, Fujikura E, Sato S, Aoki T, Musha H, Kikuchi K, Nagasawa T, Sato H, Ito S, Miyazaki M. A Catastrophic Case of Idiopathic Cholesterol Crystal Embolism with Multiple Lethal Complications: A Labyrinth Underneath the Diagnosis of Skin Ulcers in Chronic Kidney Disease Patients. Intern Med. 2019 Jun 15;58(12):1753-1758. doi: 10.2169/internalmedicine.2378-18. Epub 2019 Feb 1.
  33. Watanabe M, Oe Y, Sato E, Sekimoto A, Sato H, Ito S, Takahashi N. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F654-F659. doi: 10.1152/ajprenal.00489.2018. Epub 2019 Jan 23.
  34. Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.
  35. Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S. Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats. Clin Exp Nephrol. 2019 May;23(5):597-605. doi: 10.1007/s10157-019-01689-7. Epub 2019 Jan 7.
  36. Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S. JSH Statement: Kyoto declaration on hypertension research in Asia. Hypertens Res. 2019 Jun;42(6):759-760. doi: 10.1038/s41440-018-0172-8. Epub 2019 Jan 7.
  37. Mishima E, Abe T. Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides. Methods Mol Biol. 2019;1870:179-187. doi: 10.1007/978-1-4939-8808-2_13.
  38. Wang A, Hirose T, Ohsaki Y, Takahashi C, Sato E, Oba-Yabana I, Kinugasa S, Muroya Y, Ito S, Mori T. Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats. Clin Exp Nephrol. 2019 Apr;23(4):455-464. doi: 10.1007/s10157-018-1669-9. Epub 2018 Nov 13.
  39. Tezuka Y, Nakaya I, Nakayama K, Nakayama M, Yahata M, Soma J. Methylglyoxal as a prognostic factor in patients with chronic kidney disease. Nephrology (Carlton). 2019 Sep;24(9):943-950. doi: 10.1111/nep.13526. Epub 2019 Apr 29.
  40. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study. Diabetes Obes Metab. 2019 Apr;21(4):791-800. doi: 10.1111/dom.13575. Epub 2018 Dec 6.
TOP